Eribulin as 1st Line Treatment in Elderly Patients With Advanced Breast Cancer
Status: TERMINATED
Study type: INTERVENTIONAL
Conditions: Breast Cancer|Adenocarcinoma
Interventions: DRUG: Eribulin mesilate
Sponsor: Swiss Group for Clinical Cancer Research